A Periodic Transaction Report filed with the U.S. House of Representatives shows Hon. Julia Letlow purchased shares of CVS Health Corp (ticker: CS) on October 25, 2024. The transaction was made by the member of Congress herself and is valued between $1,001 and $15,000, according to the disclosed amount range.
The report lists the holding as being maintained through a Merrill Lynch Investment Account, identified in the filing as Account #025. Under the STOCK Act’s classification system used by whoisbuyingnow.com, this transaction is logged as a ‘congress buy’ signal, reflecting a new or additional purchase of the asset.
A Notable Filing Delay
The disclosure itself was filed 290 days after the actual transaction date. The STOCK Act requires members of Congress to report qualifying transactions within 45 days of being notified of the trade. In this case, the gap between the October 25, 2024 purchase and the eventual filing significantly exceeds that window. We note this delay factually, as part of the public record, without speculating on the reasons behind it. Late filings under the STOCK Act do occur across both chambers of Congress and are not, on their own, evidence of wrongdoing.
A Curious Description
One detail in the filing stands out: while the asset is listed as CVS Health Corp under the ticker CS, the filer’s own description of the transaction reads ‘Corporate Bond.’ This wording does not match the equity ticker listed elsewhere in the same report. Periodic Transaction Reports are filled out by the filer or their representatives, and descriptive fields sometimes contain shorthand, boilerplate, or inconsistent language relative to the asset ticker also listed on the form. We are reporting the description exactly as it appears in the filing, without attempting to reconcile or reinterpret it.
As with all STOCK Act disclosures, this filing is a legally required record of a financial transaction by a sitting member of Congress, not an allegation of improper conduct. The purpose of the Act is to create transparency around potential conflicts of interest by requiring timely public reporting of trades in stocks, bonds, and other covered securities. Readers interested in the underlying filing can consult the official House of Representatives financial disclosure database for the original document and any accompanying notes.
whoisbuyingnow.com will continue tracking disclosures involving Rep. Letlow and other members of Congress as new Periodic Transaction Reports become available.